| Assessment Status | NCPE Assessment Process Complete |
| HTA ID | - |
| Drug | Dimethyl fumarate |
| Brand | Tecfidera® |
| Indication | For the treatment of adult patients with relapsing remitting multiple sclerosis (MS) |
| Assessment Process | |
| Rapid review commissioned | 04/02/2014 |
| Rapid review completed | 06/03/2014 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Recommended |
| Full submission received from Applicant | 16/07/2014 |
| NCPE assessment completed | 14/01/2015 |
| NCPE assessment outcome | Reimbursement not recommended |
14/04/2015
Following pricing negotiation, the HSE has approved reimbursement of Tecfidera® under the High Tech Drugs Scheme.
